Patents Assigned to Centogene IP GmbH
  • Combination of a Compound Having the Ability to Rearrange a Lysosomal Enzyme and Ambroxol and/or a Derivative of Ambroxol
    Publication number: 20210228560
    Abstract: The present invention is related to a combination comprising a first constituent and a second constituent, wherein the first constituent is a compound having the ability to rearrange a lysosomal protein, wherein the lysosomal protein has a reduced activity, and wherein the second constituent is Ambroxol and/or a derivative of Ambroxol.
    Type: Application
    Filed: April 5, 2021
    Publication date: July 29, 2021
    Applicant: Centogene IP GmbH
    Inventors: Jan Lukas, Anahit Pews-Davtyan, Matthias Beller, Arndt Rolfs
  • Method for the Diagnosis of Cystic Fibrosis
    Publication number: 20190128901
    Abstract: The present invention is related to a method for diagnosing cystic fibrosis in a subject comprising a step a), wherein the step a) comprises detecting a biomarker in a sample from the subject, wherein the sample is a sample selected from the group comprising blood, a blood product, urine, saliva, cerebrospinal liquid, stool, tissue and lymph liquid.
    Type: Application
    Filed: April 24, 2017
    Publication date: May 2, 2019
    Applicant: Centogene IP GmbH
    Inventor: Claudia Cozma
  • COMBINATION OF A COMPOUND HAVING THE ABILITY TO REARRANGE A LYSOSOMAL ENZYME AND AMBROXOL AND/OR A DERIVATIVE OF AMBROXOL
    Publication number: 20150258081
    Abstract: It is herewith declared that the information stored on the carrier which is submitted together with the international patent application is identical to the written sequence listing of the international patent application.
    Type: Application
    Filed: December 21, 2012
    Publication date: September 17, 2015
    Applicant: Centogene IP GmbH
    Inventors: Jan Lukas, Anahit Pews-Davtyan, Mathias Beller, Arndt Rolfs